The Translational Health Science and Technology Institue (THSTI), BRIC, and DNDi are organizing a session on drug discovery with insights from industry experts.
The event can be joined both in-person or virtually. Registration is mandatory.
| Leveraging AI in accelerating drug discovery for global health diseases Anil Koul, Vice President, R&D, Johnson and Johnsons, Belgium and Professor, London School of Hygiene and Tropical Medicine |
| From idea to patient: A journey of drug discovery and development Shridhar Narayanan, CEO, Foundation for Neglected Disease Research |
| Discovery of novel treatments of visceral leishmaniasis Peter Sjö, Head of Discovery Projects, DNDi |
| Drug repurposing strategies for Japanese encephalitis Manjula Kalia, Professor, Regional Centre for Biotechnology |
